# Michael Vieth

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/michael-vieth/

## Facts

| Field | Value |
| --- | --- |
| Citations | 37,923 |
| Field | Esophageal Cancer Research and Treatment |
| h-index | 99 |
| i10-index | 400 |
| Last Known Institution | National University of Singapore |
| OpenAlex ID | https://openalex.org/A5012621209 |
| ORCID iD | https://orcid.org/0000-0002-4336-7721 |
| Works | 889 |

## Researcher papers

- [Endoscopic submucosal dissection: European Society of Gastrointestinal Endoscopy (ESGE) Guideline](https://scholariq.org/papers/endoscopic-submucosal-dissection-european-society-of-gastrointestinal-endoscopy/)
- [The Development and Validation of an Endoscopic Grading System for Barrett’s Esophagus: The Prague C & M Criteria](https://scholariq.org/papers/the-development-and-validation-of-an-endoscopic-grading-system-for-barrett-s/)
- [Endoscopic submucosal dissection for superficial gastrointestinal lesions: European Society of Gastrointestinal Endoscopy (ESGE) Guideline – Update 2022](https://scholariq.org/papers/endoscopic-submucosal-dissection-for-superficial-gastrointestinal-lesions/)
- [Nonpolypoid neoplastic lesions of the colorectal mucosa](https://scholariq.org/papers/nonpolypoid-neoplastic-lesions-of-the-colorectal-mucosa/)
- [In vivo imaging using fluorescent antibodies to tumor necrosis factor predicts therapeutic response in Crohn's disease](https://scholariq.org/papers/in-vivo-imaging-using-fluorescent-antibodies-to-tumor-necrosis-factor-predicts/)
- [Consensus Statements for Management of Barrett's Dysplasia and Early-Stage Esophageal Adenocarcinoma, Based on a Delphi Process](https://scholariq.org/papers/consensus-statements-for-management-of-barrett-s-dysplasia-and-early-stage/)
- [Local endoscopic therapy for intraepithelial high-grade neoplasia and early adenocarcinoma in Barrett's oesophagus: acute-phase and intermediate results of a new treatment approach](https://scholariq.org/papers/local-endoscopic-therapy-for-intraepithelial-high-grade-neoplasia-and-early/)
- [Efficacy of Budesonide Orodispersible Tablets as Induction Therapy for Eosinophilic Esophagitis in a Randomized Placebo-Controlled Trial](https://scholariq.org/papers/efficacy-of-budesonide-orodispersible-tablets-as-induction-therapy-for/)
- [Effect of <i>Helicobacter pylori</i> on gastrointestinal microbiota: a population-based study in Linqu, a high-risk area of gastric cancer](https://scholariq.org/papers/effect-of-i-helicobacter-pylori-i-on-gastrointestinal-microbiota-a-population/)
- [Endoscopic submucosal dissection techniques and technology: European Society of Gastrointestinal Endoscopy (ESGE) Technical Review](https://scholariq.org/papers/endoscopic-submucosal-dissection-techniques-and-technology-european-society-of/)
- [A randomised, double-blind trial comparing budesonide formulations and dosages for short-term treatment of eosinophilic oesophagitis](https://scholariq.org/papers/a-randomised-double-blind-trial-comparing-budesonide-formulations-and-dosages/)
- [Budesonide Orodispersible Tablets Maintain Remission in a Randomized, Placebo-Controlled Trial of Patients With Eosinophilic Esophagitis](https://scholariq.org/papers/budesonide-orodispersible-tablets-maintain-remission-in-a-randomized-placebo/)

## Researcher topics

- [Esophageal Cancer Research and Treatment](https://scholariq.org/topics/esophageal-cancer-research-and-treatment/)
- [Gastric Cancer Management and Outcomes](https://scholariq.org/topics/gastric-cancer-management-and-outcomes/)
- [Helicobacter pylori-related gastroenterology studies](https://scholariq.org/topics/helicobacter-pylori-related-gastroenterology-studies/)
- [Eosinophilic Esophagitis](https://scholariq.org/topics/eosinophilic-esophagitis/)
- [Gastroesophageal reflux and treatments](https://scholariq.org/topics/gastroesophageal-reflux-and-treatments/)

## Researcher university

- [National University of Singapore](https://scholariq.org/institutions/national-university-of-singapore/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.